Eva Lindskog
GE Healthcare
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Eva Lindskog.
Biotechnology Progress | 2013
Marie-Françoise Clincke; Carin Mölleryd; Ye Zhang; Eva Lindskog; Kieron Walsh; Veronique Chotteau
High cell density perfusion process of antibody producing CHO cells was developed in disposable WAVE Bioreactor™ using external hollow fiber filter as cell separation device. Both “classical” tangential flow filtration (TFF) and alternating tangential flow system (ATF) equipment were used and compared. Consistency of both TFF‐ and ATF‐based cultures was shown at 20–35 × 106 cells/mL density stabilized by cell bleeds. To minimize the nutrients deprivation and by‐product accumulation, a perfusion rate correlated to the cell density was applied. The cells were maintained by cell bleeds at density 0.9–1.3 × 108 cells/mL in growing state and at high viability for more than 2 weeks. Finally, with the present settings, maximal cell densities of 2.14 × 108 cells/mL, achieved for the first time in a wave‐induced bioreactor, and 1.32 × 108 cells/mL were reached using TFF and ATF systems, respectively. Using TFF, the cell density was limited by the membrane capacity for the encountered high viscosity and by the pCO2 level. Using ATF, the cell density was limited by the vacuum capacity failing to pull the highly viscous fluid. Thus, the TFF system allowed reaching higher cell densities. The TFF inlet pressure was highly correlated to the viscosity leading to the development of a model of this pressure, which is a useful tool for hollow fiber design of TFF and ATF. At very high cell density, the viscosity introduced physical limitations. This led us to recommend cell densities under 1.46 × 108 cell/mL based on the analysis of the theoretical distance between the cells for the present cell line.
Biotechnology Progress | 2013
Marie-Françoise Clincke; Carin Mölleryd; Puneeth K. Samani; Eva Lindskog; Eric Faldt; Kieron Walsh; Veronique Chotteau
A high cell density perfusion process of monoclonal antibody (MAb) producing Chinese hamster ovary (CHO) cells was developed in disposable WAVE Bioreactor™ using external hollow fiber (HF) filter as cell separation device. Tangential flow filtration (TFF) and alternating tangential flow (ATF) systems were compared and process applications of high cell density perfusion were studied here: MAb production and cryopreservation. Operations by perfusion using microfiltration (MF) or ultrafiltration (UF) with ATF or TFF and by fed‐batch were compared. Cell densities higher than 108 cells/mL were obtained using UF TFF or UF ATF. The cells produced comparable amounts of MAb in perfusion by ATF or TFF, MF or UF. MAbs were partially retained by the MF using ATF or TFF but more severely using TFF. Consequently, MAbs were lost when cell broth was discarded from the bioreactor in the daily bleeds. The MAb cell‐specific productivity was comparable at cell densities up to 1.3 × 108 cells/mL in perfusion and was comparable or lower in fed‐batch. After 12 days, six times more MAbs were harvested using perfusion by ATF or TFF with MF or UF, compared to fed‐batch and 28× more in a 1‐month perfusion at 108 cells/mL density. Pumping at a recirculation rate up to 2.75 L/min did not damage the cells with the present TFF settings with HF short circuited. Cell cryopreservation at 0.5 × 108 and 108 cells/mL was performed using cells from a perfusion run at 108 cells/mL density. Cell resuscitation was very successful, showing that this system was a reliable process for cell bank manufacturing.
Biotechnology Progress | 2006
Karin Calles; Ingrid Svensson; Eva Lindskog; Lena Häggström
The effects of conditioned medium (CM) and passage number on Spodoptera frugiperda Sf9 cell physiology and productivity have been studied. Low passage (LP) cells at passages 20–45 were compared to high passage (HP) cells at passages >100. Addition of 20% CM or 10 kDa filtrated CM to LP cells promoted growth. LP cells passed a switch in growth kinetics, characterized by a shorter lag phase and a higher growth rate, after 30–40 passages. After this point, CM lost its stimulating effect on proliferation. HP cells displayed a still shorter lag phase and reached the maximum cell density 24–48 earlier than LP cells. HP cells also exhibited higher specific productivity of recombinant protein compared to LP cells, when infected with baculovirus during the initial 48 h of culture. The specific productivity of LP cells was decreased by 30–50% by addition of 20% CM or 10 kDa filtrated CM, whereas addition of CM to cells having passed the switch in growth kinetics had no negative effect on productivity. Cell cycle analysis showed that a large proportion of HP cells, >60%, was transiently arrested in G2/M after inoculation. In LP cultures this proportion was lower, 40–45%, and addition of CM decreased the arrested population further. This correlated to the cell size, the HP cells being the largest: HP cells > LP > LP + 20% CM > LP + 20% 10 kDa filtrated CM. Since the degree of synchronization in G2sol;M correlated to the productivity, yeastolate limitation was used to achieve 85% G2/M synchronized cells. In this culture the specific productivity was maintained during a prolonged production phase and a 69% higher volumetric yield was obtained. The results suggest that a decreasing degree of synchronization during the course of culture partly explains the cell‐density‐dependent drop in productivity in Sf9 cells.
22d ESACT (European Society for Animal Cell Technology), May 15-18, 2011, Vienna, Austria | 2011
Marie-Françoise Clincke; Carin Mölleryd; Ye Zhang; Eva Lindskog; Kieron Walsh; Veronique Chotteau
Major advantages of perfusion are high cell numbers and high total production in a relatively small size bioreactor. Moreover, perfusion is optimal when the product of interest is unstable or if th ...
Archive | 2018
Kenneth P. Clapp; Andreas Castan; Eva Lindskog
Abstract Modern bioprocesses have become quite diverse with highly specialized designs serving a broad spectrum of customers and their products. With the specialization, there has been a growth in platform technologies, starting with the cell line or organism and extending into equipment design. Despite the breadth and diversity of equipment designs, all equipment must be scalable and address the needs of the related stakeholders, from the scientist/engineer to the maintenance personnel. In this chapter, the requirements of upstream bioprocessing equipment are introduced and discussed in detail from an engineering standpoint, with the bioreactor in focus, and including examples of available bioreactor technology.
Archive | 2010
Klaus Gebauer; Eva Lindskog; Lars Magnusson
Archive | 2012
Veronique Chotteau; Rafael Diana; Christian Kaisermayer; Eva Lindskog; Craig Robinson; Jimmie L. Rucker; Kieron Walsh
Archive | 2012
Christian Kaisermayer; Eva Lindskog
245th National Meeting of the American-Chemical-Society (ACS), APR 07-11, 2013, New Orleans, LA | 2013
Andreas Castan; Erik Fäldt; Carin Mölleryd; Eva Lindskog; Veronique Chotteau
Bioprocessing Summit, Boston, MA, USA, Aug. 22-25, 2011 - Optimizing Cell Culture Technology | 2011
Marie-Françoise Clincke; Carin Mölleryd; Puneeth K. Samani; Ye Zhang; Eva Lindskog; Kieron Walsh; Veronique Chotteau